2019
DOI: 10.1186/s13613-019-0553-4
|View full text |Cite
|
Sign up to set email alerts
|

Trisodium citrate 4% versus heparin as a catheter lock for non-tunneled hemodialysis catheters in critically ill patients: a multicenter, randomized clinical trial

Abstract: Background Non-tunneled hemodialysis catheters are currently used for critically ill patients with acute kidney injury requiring extracorporeal renal replacement therapy. Strategies to prevent catheter dysfunction and infection with catheter locks remain controversial. Methods In a multicenter, randomized, controlled, double-blind trial, we compared two strategies for catheter locking of non-tunneled hemodialysis catheters, namely trisodium citrate at 4% (intervention g… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
30
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(32 citation statements)
references
References 28 publications
0
30
0
Order By: Relevance
“…Thrombosis is a disease involving multiple factors and systems and a major contributor to global health burden [23]. Many approaches, such as changes in the diameter of catheter [24], tuning of catheter-to-vein ratio [25], novel catheter surface coatings [26], use of catheter-locking solutions [27] or anticoagulants [28], and handgrip exercise [29], have been investigated to prevent CRT. Numerous reports on CRT were clinical studies.…”
Section: Discussionmentioning
confidence: 99%
“…Thrombosis is a disease involving multiple factors and systems and a major contributor to global health burden [23]. Many approaches, such as changes in the diameter of catheter [24], tuning of catheter-to-vein ratio [25], novel catheter surface coatings [26], use of catheter-locking solutions [27] or anticoagulants [28], and handgrip exercise [29], have been investigated to prevent CRT. Numerous reports on CRT were clinical studies.…”
Section: Discussionmentioning
confidence: 99%
“…While not uniformly consistent, some studies suggest a reduced incidence of catheter-related bacteremia with citrate use [ 18 ]. Importantly, most of these studies were not conducted in AKI requiring RRT, and the largest study to date to compare heparin vs. citrate use in patients with AKI requiring RRT via non-tunneled dialysis catheter noted no difference in event-free survival of catheter, thrombosis, infection, or adverse events [ 19 ]. Thus, currently, no uniform recommendation regarding catheter-locking can be suggested.…”
Section: Discussionmentioning
confidence: 99%
“…While not uniformly consistent, some studies suggest a reduced incidence of catheter-related bacteremia with citrate use [16]. Importantly, most of these studies were not conducted in AKI requiring RRT, and the largest study to date to compare heparin vs. citrate use in patients with AKI requiring RRT via non-tunneled dialysis catheter noted no difference in event-free survival of catheter, thrombosis, infection, or adverse events [17]. Thus, currently, no uniform recommendation regarding catheter-locking can be suggested.…”
Section: Discussionmentioning
confidence: 99%